Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis
Authors:
- 12 May 2011
- journal article
- research article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 27 (7) , 1425-1429
Abstract
(2011). Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis. Current Medical Research and Opinion: Vol. 27, No. 7, pp. 1425-1429. doi: 10.1185/03007995.2011.583230Keywords
This publication has 12 references indexed in Scilit:
- Is Pharmacologic Care of Chronic Obstructive Pulmonary Disease Consistent with the Guidelines?Population Health Management, 2010
- Long-term Use of Inhaled Corticosteroids and the Risk of Pneumonia in Chronic Obstructive Pulmonary DiseaseArchives of internal medicine (1960), 2009
- Medication adherence issues in patients treated for COPDInternational Journal of Chronic Obstructive Pulmonary Disease, 2008
- The Quality of Obstructive Lung Disease Care for Adults in the United States as Measured by Adherence to Recommended ProcessesChest, 2006
- Development of a COPD severity scoreCurrent Medical Research and Opinion, 2006
- Patient adherence with COPD therapyEuropean Respiratory Review, 2005
- A dynamic population model of disease progression in COPDEuropean Respiratory Journal, 2005
- Disease Management Opportunities for Chronic Obstructive Pulmonary Disease: Gaps Between Guidelines and Current PracticeDisease Management, 2002
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Suboptimal Medical Therapy in COPDChest, 2000